<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">477119549</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180405111632.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170330e19960301xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF00240036</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF00240036</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Is cysteine residue important in FITC-sensitive ATP-binding site of P-type ATPases? A commentary to the state of the art</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Albert Breier, Attila Ziegelhöffer, Konrad Famulsky, Marek Michalak, Ján Slezák]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Treatment of P-type ATPases (from mammalian sources) by fluorescein isothiocyanate (ITC) revealed the ITC label on a lysine residue that was than considered as essential for binding of ATP in the ATP-binding site of these enzymes. On the other hand, experiments with site directed mutagenesis excluded the presence of an essential lysine residue that would be localized in the ATP binding sites of ATPases. Other previous studies, including those of ourselves, indicated that the primary site of isothiocyanate interaction may be the sulflhydryl group of a cysteine residue and this may be essential for binding of ATP. In addition considerable knowledge accumulated since yet also about the differences in stability of reaction product of isothiocyanates with SH- or NH2- groups. Based upon evaluation of the data available up to now, in present paper the following tentative roles for lysine and cysteine residues located in the ATP-binding site of P-type ATPases are proposed: The positively charged micro-domain of the lysine residue may probably attract the negatively charged phosphate moiety of the ATP molecule whereas the cysteine residue may probably be responsible for recognition and binding of ATP by creation of a proton bridge with the amino group in position 6 on the adenosine ring of ATP.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Kluwer Academic Publishers, 1996</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">isothiocyanates</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">lysine and cysteine in the ATP-binding site</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">P-type ATPases</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">(Na++K+)-ATPase, Ca2+ ATPase</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Breier</subfield>
   <subfield code="D">Albert</subfield>
   <subfield code="u">Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, Vlárska 5, 833 34, Bratislava, Slovak Republic</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Ziegelhöffer</subfield>
   <subfield code="D">Attila</subfield>
   <subfield code="u">Institute for Heart Research, Slovak Academy of Sciences, DÚbravská cesta 9, 842 33, Bratislava, Slovak Republic</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Famulsky</subfield>
   <subfield code="D">Konrad</subfield>
   <subfield code="u">Department of Biochemistry, Cardiovascular Disease Research Group, University of Alberta, Edmonton, 424 Heritage Medical Research Center, T6G 2S2, Edmonton, Alberta, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Michalak</subfield>
   <subfield code="D">Marek</subfield>
   <subfield code="u">Department of Biochemistry, Cardiovascular Disease Research Group, University of Alberta, Edmonton, 424 Heritage Medical Research Center, T6G 2S2, Edmonton, Alberta, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Slezák</subfield>
   <subfield code="D">Ján</subfield>
   <subfield code="u">Institute for Heart Research, Slovak Academy of Sciences, DÚbravská cesta 9, 842 33, Bratislava, Slovak Republic</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Molecular and Cellular Biochemistry</subfield>
   <subfield code="d">Kluwer Academic Publishers; http://www.wkap.nl</subfield>
   <subfield code="g">160-161/1(1996-03-01), 89-93</subfield>
   <subfield code="x">0300-8177</subfield>
   <subfield code="q">160-161:1&lt;89</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">160-161</subfield>
   <subfield code="o">11010</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF00240036</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF00240036</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Breier</subfield>
   <subfield code="D">Albert</subfield>
   <subfield code="u">Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, Vlárska 5, 833 34, Bratislava, Slovak Republic</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ziegelhöffer</subfield>
   <subfield code="D">Attila</subfield>
   <subfield code="u">Institute for Heart Research, Slovak Academy of Sciences, DÚbravská cesta 9, 842 33, Bratislava, Slovak Republic</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Famulsky</subfield>
   <subfield code="D">Konrad</subfield>
   <subfield code="u">Department of Biochemistry, Cardiovascular Disease Research Group, University of Alberta, Edmonton, 424 Heritage Medical Research Center, T6G 2S2, Edmonton, Alberta, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Michalak</subfield>
   <subfield code="D">Marek</subfield>
   <subfield code="u">Department of Biochemistry, Cardiovascular Disease Research Group, University of Alberta, Edmonton, 424 Heritage Medical Research Center, T6G 2S2, Edmonton, Alberta, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Slezák</subfield>
   <subfield code="D">Ján</subfield>
   <subfield code="u">Institute for Heart Research, Slovak Academy of Sciences, DÚbravská cesta 9, 842 33, Bratislava, Slovak Republic</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Molecular and Cellular Biochemistry</subfield>
   <subfield code="d">Kluwer Academic Publishers; http://www.wkap.nl</subfield>
   <subfield code="g">160-161/1(1996-03-01), 89-93</subfield>
   <subfield code="x">0300-8177</subfield>
   <subfield code="q">160-161:1&lt;89</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">160-161</subfield>
   <subfield code="o">11010</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
